Sirona Capital invests in the future of healthcare innovation and therapeutics. As a dedicated healthcare venture capital fund, we are committed to identifying and supporting visionary entrepreneurs who are reshaping the landscape of healthcare and life sciences.
External link for Sirona Capital
First biotech IPO on NASDAQ in 2024. Exciting times! https://lnkd.in/gv4GNQDu
CG Oncology is ringing in its next chapter and listing on Nasdaq! 🛎️🧬 At the intersection of science and patient care, $CGON is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. Congratulations to the entire CG Oncology team on this milestone. 🎉
Congratulations Synnovation Therapeutics!
Today we announced the closing of $102 million in Series A funding, and the appointment of Jigar Raythatha of Third Rock Ventures and Thilo Schroeder, Ph.D. of Nextech Invest to our Board of Directors. We are appreciative for the support of our new and existing investors as we continue to work towards changing the lives of patients living with cancer. More in today’s release: https://lnkd.in/eTvuKwZp Third Rock Ventures, Nextech Ventures, Lilly Asia Ventures 礼来亚洲基金, Sirona Capital, Cormorant Asset Management, LP